Nuclear Cardiology

Single photon computed tomography (SPECT) and positron emission tomography (PET) molecular imaging are used as primary cardiac imaging modalities to evaluate the function of the heart. It uses radioactive isotopes attached to sugars that are metabolized by cardiomyocytes. This creates an image of the metabolic activity of the heart and shows areas of ischemia or infarct. Other radiotracers can image the heart to diagnosis cardiac amyloidosis and sarcoidosis. 

Video of ASNC President Mouaz Al-Mallah, MD, explaining some long-COVID cardiac symptoms might be due to coronary microvascular dysfunction. He was part of a recent study that used PET top assess myocardial perfusion that found there is impaired microvascular flow in long-COVID patients.

PET imaging helps assess coronary microvascular dysfunction in long COVID patients

Researchers noted that patients appeared to have myocarditis at first, but a closer examination revealed it was something else entirely. 

doctor in handcuffs after being arrested

Cardiologist to pay $6.5M after trading kickbacks for imaging referrals in complex fraud scheme

In addition to the hefty fine, the New York physician has agreed to relinquish ownership of his cardiology practice after exchanging kickbacks for PET and SPECT referrals for more than a decade.

Video interview with ASNC President President Mouaz Al-Mallah, MD, who explains why nuclear cardiology needs to upgrade its technology to be competitive. #ASNC #ASNC2023 #ASNC23

Previewing ASNC 2023: Why nuclear cardiology needs to evolve

ASNC President President Mouaz Al-Mallah, MD, said nuclear cardiology needs to upgrade old imaging systems and embrace new technology to deliver better value for patients. 

Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, discusses how artificial intelligence (AI) is impacting cardiac imaging.

What is the ROI for adopting AI in cardiac imaging?

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies. 

To hear about key trends in cardiac imaging, Cardiovascular Business spoke with two experts in cardiac imaging at American College of Cardiology (ACC) 2023 meeting, Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, and Rob Beanlands, MD, is director of the National Cardiac PET Centre at the University of Ottawa Heart Institute, Canada.

What's new in cardiac imaging? 2 experts discuss the latest trends

Marcelo DiCarli, MD, and Rob Beanlands, MD, shared their thoughts on the current state of cardiac imaging at ACC.23. 

Janet Wei at Cedars-Sinai Hospital explains INOCA and MINOCA at ACC 2023.

Understanding INOCA and MINOCA epidemiology

Janet Wei, MD, associate medical director of the Biomedical Imaging Research Institute, and co-director of the stress echocardiography lab at Cedars-Sinai Hospital, explains the current information on the INOCA and MINOCA.

VIDEO: American Society of Nuclear Cardiology (ASNC) President Mouaz Al-Mallah, MD, chair of cardiovascular PET and associate director of nuclear cardiology, Houston Methodist DeBakey Heart and Vascular Center, and ASNC President-elect Larry Phillips, MD, director of nuclear cardiology, NYU Langone, outline the new technologies available and why upgrading cardiac nuclear labs matters and what is the ROI. #ASNC

What is the ROI for upgrading nuclear cardiology labs?

Some nuclear cardiology labs are still using SPECT systems that are 20-25 years old. Is it time to make an upgrade? 

Watch the VIDEO ASNC President Mouaz Al-Mallah explains trends in nuclear cardiology. American Society of Nuclear Cardiology sees future opportunities in nuclear imaging outside of perfusion imaging. #ASNC

ASNC leaders reflect on the state of nuclear cardiology

ASNC President Mouaz Al-Mallah, MD, and ASNC President-elect Larry Phillips, MD, discussed some of the key trends in cardiac molecular imaging at ACC.23.